XML 25 R8.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Common stock
Employee
Paid-in capital
Paid-in capital
Employee
Retained earnings (accumulated deficit)
Accumulated other comprehensive loss
Balance at beginning of year (in shares) at Dec. 31, 2021   22,018,000          
Balance at beginning of year at Dec. 31, 2021 $ 255,646 $ 220   $ 271,556   $ 17,419 $ (33,549)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (6,166)         (6,166)  
Other Comprehensive Income (Loss), Net of Tax (2,305)           (2,305)
Performance shares issued to employees (in shares)     167,000        
Performance shares issued to employees 0   $ 2   $ (2)    
Net issuance of restricted shares granted to employees (in shares)     260,000        
Net issuance of restricted shares granted to employees and directors     $ 3   (3)    
Stock compensation expense $ 3,861     3,861      
Net exercise of stock options (in shares) 60,000 25,000          
Net exercise of stock options $ 233     233      
Shares effectively repurchased for required employee withholding taxes (in shares)   (93,000)          
Shares effectively repurchased for required employee withholding taxes $ (1,067) $ (1)   (1,066)      
Stock Repurchased During Period, Shares (597,195) (597,000)          
Stock Repurchased During Period, Value $ (6,320) $ (6)   0   6,314  
Dividends (3,794)         (3,794)  
Balance at end of year (in shares) at Dec. 31, 2022   21,780,000          
Balance at end of year at Dec. 31, 2022 240,088 $ 218   274,579   1,145 (35,854)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (8,412)         (8,412)  
Other Comprehensive Income (Loss), Net of Tax 2,355           2,355
Performance shares issued to employees (in shares)     120,000        
Performance shares issued to employees 0   $ 1   (1)    
Net issuance of restricted shares granted to employees (in shares)     325,000        
Net issuance of restricted shares granted to employees and directors     $ 3   (3)    
Stock compensation expense 3,690     3,690      
Shares effectively repurchased for required employee withholding taxes (in shares)   (92,000)          
Shares effectively repurchased for required employee withholding taxes $ (538) $ (1)   (537)      
Stock Repurchased During Period, Shares (320,204) (320,000)          
Stock Repurchased During Period, Value $ (2,539) $ (3)   0   (2,536)  
Dividends (3,765)         (3,765)  
Balance at end of year (in shares) at Dec. 31, 2023   21,813,000          
Balance at end of year at Dec. 31, 2023 230,879 [1] $ 218   277,728   13,568 [1] (33,499)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (15,165)         (15,165)  
Other Comprehensive Income (Loss), Net of Tax 15,184           15,184
Performance shares issued to employees (in shares)     152,000        
Performance shares issued to employees 0   $ 2   (2)    
Net issuance of restricted shares granted to employees (in shares)     302,000        
Net issuance of restricted shares granted to employees and directors     $ 3   $ (3)    
Stock compensation expense 3,924     3,924      
Shares effectively repurchased for required employee withholding taxes (in shares)   (111,000)          
Shares effectively repurchased for required employee withholding taxes (1,082) $ (1)   (1,081)      
Dividends (3,817)         (3,817)  
Balance at end of year (in shares) at Dec. 31, 2024   22,156,000          
Balance at end of year at Dec. 31, 2024 $ 229,923 $ 222   $ 280,566   $ 32,550 $ (18,315)
[1] Cash dividend declared per share of common stock, were $0.17, $0.17 and $0.17 in 2022, 2023 and 2024, respectively.